Renal manifestations in HIV-infected Jamaican children

West Indian Medical Journal

Volumn 57, Issue 3, 2008, Pages 246-252

  Steel Duncan, J ^a   Miller, M ^a,b   Pierre, R B ^a,b   Dunkley Thompson, J ^a   Palmer, P ^a   Evans Gilbert, T ^b   Rodriquez, B ^c,d   Christie, Celia D C ^a,b  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

^b UNIVERSITY HOSPITAL OF THE WEST INDIES   (Jamaica)

^c Bustamante Hospital for Children   (Jamaica)

^d Department of Paediatric Medicine   (Jamaica)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INDINAVIR; LAMIVUDINE; NEVIRAPINE; STEROID; ZIDOVUDINE;

AGE; ARTICLE; CHILD; CHRONIC KIDNEY FAILURE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; ENTEROBACTER; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; HEALTH CARE FACILITY; HEMARTHROSIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERSTITIAL NEPHRITIS; JAMAICA; KIDNEY DISEASE; KIDNEY FAILURE; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEPHROLITHIASIS; NEPHROTIC SYNDROME; PANTOEA AGGLOMERANS; PROTEINURIA; PROTEUS; PSEUDOMONAS; RECURRENCE RISK; SALMONELLA; SEX RATIO; STREPTOCOCCUS; SURVIVAL TIME; TREATMENT OUTCOME; URINARY TRACT INFECTION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; INDINAVIR; INFANT; INFANT, NEWBORN; JAMAICA; MALE; NEPHRITIS, INTERSTITIAL; NEPHROLITHIASIS; PROSPECTIVE STUDIES;

EID: 55749095843     PISSN: 00433144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Joint United Nations Programmeme on HIV/AIDS (UNAIDS). Report on the global AIDS epidemic. UNAIDS, May 2006. Available at: http://www.unaids.org/en/HIV_data/2006GlobalReport
2. Christie CDC, Bain B, Pierre R, Smikle MF, Evans-Gilbert T, Fredericks J et al. HIV/AIDS in women, infants, children and adolescents in Jamaica: A further call to action. West Indian Med J 2001; 50: 258-62.
3. Ministry of Health (MOH). National HIV/STI Prevention and Control Prograrmne, Jamaica AIDS Report 2006, Kingston Jamaica: MOH 2006. Available at: http.//www.jamaica-nap.org
4. Gupta S, Eustace J, Winston J, Boydstun I, Ahuja T, Rodriquez R et al. Guidelines for the management of chronic kidney disease in HIV-infected patients: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2005; 40: 1559-85.
5. Ray PE, Xu L, Rakusan T, Liu XH. A 20-year history of childhood HIV-associated nephropathy. Pediatr Nephrol 2004; 19: 1075-92.
6. Ray PE, Rakusan T, Loechelt BJ, Selby DM, Liu XH, Chandra RS. Human immunodeficiency virus (HIV)-associated nephropathy in children from the Washington, DC area: 12 years' experience. Semin Nephrol 1998; 8: 396-405.
7. Shah I. Response of HIV-associated proteinuria to antiretroviral therapy in HIV-1-infected children. Braz J Infect Dis 2006; 10: 408-10.
8. Inguilli E, Tejani A, Fikrig S, Nicastri A, Chen CK, Pomrantz A. Nephrotic syndrome associated with acquired immunodeficiency syndrome in children. J Pediatr 1991; 119: 710-6.
9. Ahuja T, Abbott K, Pack L, Kuo YF. HIV-associated nephropathy and end-stage renal disease in children in the United States. Pediatr Nephrol 2004; 19: 808-11.
10. Rajpoot D, Kaupke CJ, Vaziri ND, Rao TK, Pomrantz A, Fikrig S. Childhood AIDS nephropathy: a 10-year experience. J Natl Med Assoc 1996; 88: 493-8.
11. Strauss J, Abitbol C, Zilleruelo G, Scott G, Paredes A, Malaga S et al. Renal disease in children with the acquired immunodeficiency syndrome. N Engl J Med 1989; 321: 625-30.
12. Zilleruelo G, Strauss J. HIV nephropathy in children. Pediatr Clin North Am 1995; 42: 1469-85.
13. Christie CDC. A paediatric and perinatal HIV/AIDS leadership initiative in Kingston, Jamaica. West Indian Med J 2004; 53: 283-92.
14. Rodriquez B, Steel-Duncan JC, Pierre R, Evans-Gilbert T, Hambleton I, Palmer P et al. Socio-demographic characteristics of HIV-exposed and HIV-infected Jamaican children. West Indian Med J 2004; 53: 303-7.
15. Pierre R, Steel-Duncan JC, Evans-Gilbert T, Rodriquez B, Palmer P, MF Smikle et al. CDC-defined diseases and opportunistic infection in Jamaican children with HIV/AIDS. West Indian Med J 2004; 53: 315-21.
16. Evans-Gilbert T, Pierre R, Steel-Duncan JC, Rodriquez B, Whorms S, Hambleton I et al. Antiretroviral drug therapy in HIV-infected Jamaican children. West Indian Med J 2004; 53: 322-6.
17. Palmer P, Anderson-Allen MM, Billings CC, Moore JT, McDonald-Kerr C, Steel-Duncan JC et al. Nursing interventions in the Kingston Paediatric and Perinatal HIV/AIDS Programme in Jamaica. West Indian Med J 2004; 53: 327-31.
18. Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine for estimating glomerular filtration rate in infants, children and adolescents. Pediatr Clin North Am 1987; 34: 571-90.
19. Strauss J, Zilleruelo G, Abitbol C, Montane B, Pardo V. Human immunodeficiency virus nephropathy. Pediatr Nephrol 1993; 7: 220-5.
20. Abrams EJ, Weedon J, Bertolli J, Bornschlegel K, Cervia J, Mendez H et al. Aging cohort of perinatally human immunodeficiency virus-infected children in New York City. Pediatr Infect Dis J 2001; 20: 511-7.
21. Bernstein LJ, Krieger BZ, Novick B, Sicklick MJ, Rubinstein A. Bacterial infection in the acquired immunodeficiency syndrome of children. Pediatr Infect Dis J 1985; 4: 472-5.
22. Kransinski K, Borkowsky W, Bonk S, Lawrence R, Chandwani S. Bacterial infections in human immunodeficiency virus-infected children. Pediatr Infect Dis J 1988; 7: 323-8.
23. Danker WM, Lindsey JC, Levin MJ, and the Paediatric AIDS Clinical Trials Group Protocol Teams 051, 128, 138, 144, 152, 179, 190, 220, 240, 245, 254, 300 and 327. Correlates of opportunistic infections in children infected with the human immunodeficiency virus managed before highly active antiretroviral therapy. Pediatr Infect Dis J 2001; 20: 40-8.
24. Ruiz-Contreras J, Ramos JT, Hernandez-Sampelayo T, Gurbindo MD, Garcia de Jose M, De Miguel MJ et al. Sepsis in children with human immunodeficiency virus infection. The Madrid HIV Paediatric Infection Collaborative Study Group. Pediatr Infect Dis J 1995; 14: 522-6.
25. Asharam K, Bhimma R, Adhikari M. Human immunodeficiency virus and urinary tract infections in children. Ann Trop Paediatr 2003; 23: 273-7.
26. Heyns CF, Fisher M. The urological management of the patient with acquired immunodeficiency syndrome. BJU Int 2005; 95: 709-16.
27. Mueller B, Sleasman J, Nelson R, Smith S, Deutsch P, Ju W et al. A Phase I/II study of the protease inhibitor indinavir in children with HIV infection. Pediatr 1998; 102: 101-9.
28. van Rossum AM, Dieleman JP, Fraaij PL, Cransberg K, Hartwig NG, Gyssens IC et al. Indinavir-associated asymptomatic nephrolithiasis and renal cortex atrophy in two HIV-1 infected children. AIDS 2001; 15: 1745-7.
29. Noble CB, Klein LT, Staiman VR, Neu N, Hensle TW, Berdon WE. Ureteral obstruction secondary to indinavir in the pediatric HIV population. Pediatr Radiol 1998; 28: 627-9.
30. Jaradat M, Phillips C, Yum MN, Cushing H, Moe S. Acute tubulointerstitial nephritis attributable to indinavir therapy. Am J Kidney Dis 2000; 35: E16.
31. van Rossum AM, Dieleman JP, Fraaij PL, Cransberg K, Hartwig NG, Gyssens IC et al. Persistent sterile leukocyturia is associated with impaired renal function in human immunodeficiency virus type 1-infected children treated with indinavir. Pediatr 2002; 110: e19.
32. Boubaker K, Sudre P, Bally F, Vogel G, Meuwly JY, Glauser M et al. Changes in renal function associated with indinavir. AIDS 1998; 12: F249-F54.
33. Gatti G, Vigano A, Sala N, Vella S, Bassetti M, Bassetti D et al. Indinavir pharmacokinetics and pharmacodynamics in children with human immunodeficiency virus infection. Antimicrob Agents Chemother 2000; 44: 752-5.
34. Brodie S, Keller M, Ewenstein B, Sax P. Variation in incidence of indinavir-associated nephrolithiasis among HIV-positive patients. AIDS 1998; 12: 2433-7.
35. Anochie IC, Eke FU, Okpere AN. Human immunodeficiency virus-associated nephropathy (HIVAN) in Nigerian children Pediatr Nephrol 2008; 23: 117-22.
36. Ifudu O, Rao KS, Tan CC, Fleischman H, Chirgwin E, Friedman E. Zidovudine is beneficial in human immunodeficiency virus associated nephropathy. Am J Nephrol 1995; 15: 217-21.
37. Michel C, Dosquet P, Ronco P, Mongenot B, Viron B, Mignon F. Nephropathy associated with human immunodeficiency virus: a report of 11 cases including 6 treated with zidovudine. Nephron 1992; 62: 434-40.
38. Wali RK, Drachenberg CI, Papadimitriou JC, Keay S, Ramos E. HIV-1 - associated nephropathy and response to highly-active antiretroviral therapy. Lancet 1998; 352: 783-4.
39. Kimmel PL, Mishkin GJ, Umana WO. Captopril and renal survival in patients with human immunodeficiency virus nephropathy. Am J Kidney Dis 1996; 28: 202-8.
40. Burns GC, Paul SK, Toth IR, Sivak SL. Effect of angiotensin-converting enzyme inhibition in HIV-associated nephropathy. J Am Soc Nephrol 1997; 8:1140-6.
41. Saulsbury F. Resolution of organ-specific complications of human immunodeficiency virus infection in children with the use of highly active antiretroviral therapy. Clin Infect Dis 2001; 32: 464-8.
42. Viani R, Danker W, Muelenaer P, Spector S. Resolution of HIV-associated nephrotic syndrome with highly active antiretroviral therapy delivered by gastrostomy tube. Pediatr 1999; 104: 1394-6.
43. Ray PE, Liu XH, Robinson LR, Reid W, Xu L, Owens JW et al. A novel HIV-1 transgenic rat model of childhood HIV-1 associated nephropathy. Kidney Int 2003; 63: 2242-53.
44. Ray PE, Liu X-H, Henry D, Dye L, Xu L, Orenstein JM et al. Infection of renal tubular epithelial cells with HIV-1 from children with HIV-associated nephropathy. Kidney Int 1998; 53: 1217-29.